Optimization of Drug Prescriptions in the Care Pathway for the Elderly, With the Final Objective of Reducing the Iatrogenic Risk
IATROPREV
1 other identifier
observational
1,500
1 country
1
Brief Summary
The IATROPREV project is an organizational innovation experimentation project, carried out in Hauts-de-France by the University hospitals of Amiens and Lille, the ARS and the URPS Doctors and Pharmacists of Hauts-de-France and following to the social security financing law of 2018, allowing experimentation with new organizations in the health sector, according to article 51. The objectives of this course are to improve the relevance of prescription in elderly people with multiple drugs as well as, the coordination of care between the city and the hospital through the sharing of information and the establishment of multi-professional consultations between the various care actors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
September 7, 2021
CompletedFirst Posted
Study publicly available on registry
September 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedNovember 19, 2025
November 1, 2025
4 years
September 7, 2021
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of side effect number in ederly with polymedicated drugs
Change of side effect number in ederly with polymedicated drugs
up to 4 years
Eligibility Criteria
patient hospitalized in the geriatric medicine department with olymedicated drugs
You may qualify if:
- patient hospitalized in the geriatric medicine department
- Potential involvement of a drug in hospitalization or potential or proven iatrogenic event during hospitalization;
- Numerous therapeutic modifications (3 or more);
- Drug interaction or introction of a new drug with one or more drug interactions;
- Medicinal product with a narrow therapeutic marge drug requiring close monitoring.
You may not qualify if:
- patient non hospitalized in the geriatric medicine department
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Amiens University Hospital
Amiens, 80054, France
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 7, 2021
First Posted
September 16, 2021
Study Start
September 1, 2021
Primary Completion
September 1, 2025
Study Completion
December 1, 2025
Last Updated
November 19, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share